Skip to main content

NPPA

academics

 

Clinical research courses

  • NPPA asks companies to reduce prices of anti-cancer medicines

    National pharmaceuticals pricing authority asked pharmaceutical industries to reduce prices of anticancer medicines post declining custom duty to zero. The government reduced custom duty on three Anti-cancer medicines namely, Trastuzumab Deruxtecan, Osimertinib and Durvalumab.

  • Opportunities for M.Pharm B.Pharm at NPPA, Dept of Pharmaceuticals - 16 vacancies
    A Bachelors Degree in Pharmacy from any recognized University-national or foreign. Candidates having Master degree will be given preference.
  • Career for M.Pharm B.Pharm at NPPA, Dept of Pharmaceuticals

    The National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that controls the prices of pharmaceutical drugs in India. National Pharmaceutical Pricing Authority (NPPA) was constituted vide Government of India Resolution dated 29th August, 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers as an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.

  • Opportunities for M.Pharm B.Pharm at NPPA, Dept of Pharmaceuticals

    The National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that controls the prices of pharmaceutical drugs in India. National Pharmaceutical Pricing Authority (NPPA) was constituted vide Government of India Resolution dated 29th August, 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers as an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.

  • NPPA notified ceiling prices of cardiac stent remains same as earlier

    NPPA has received requests from few companies about trade margin clarification of cardiac stents. On which, NPPA notified that ceiling prices of cardiac stent remains same as earlier without any changes as notified on 30th March 2022 till further notice.

  • NPPA will celebrate its Silver Jubilee

    To commemorate 25 years of existence of National Pharmaceutical Pricing Authority (NPPA), a programme will be organised at the Dr. Ambedkar International Centre, Janpath. Union Minister for Chemicals & Fertilizers and Health & Family Welfare Dr. Mansukh Mandaviya will grace the occasion as Chief Guest. MoS for Chemicals & Fertilizers and New & Renewable Energy will grace the occasion as Guest of Honour.

  • Opportunities for Pharmacy and allied candidates (33 posts) at NPPA, Dept of Pharmaceuticals

    The National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that controls the prices of pharmaceutical drugs in India. National Pharmaceutical Pricing Authority (NPPA) was constituted vide Government of India Resolution dated 29th August, 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers as an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.

  • NPPA condemns false statements regarding its connivance in any malpractices adopted by Pharmaceutical Companies

    National Pharmaceutical Pricing Authority is a regulatory body under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India and is committed to ensure affordability and accessibility of medicines by fixing the ceiling price for scheduled formulations and monitoring the prices of non-scheduled formulations.

  • Carbamazepine, Ranitidine and Ibuprofen cost hikes by 50 percent

    National Pharmaceutical Pricing Authority (NPPA) allows price hikes of essential medicines like Carbamazepine, Ranitidine and ibuprofen by 50 percent. They have included 9 strengths of these medicines and allows manufacturers to increase pricing after being advised by the Standing Committee on Affordable Medicines and Health Products (SCAMHP), Niti Aayog, Government of India.

  • Torrent Pharmaceutical gets exemption of DPCO for their formulation Tapentadol Nasal Spray

    National Pharmaceutical Pricing Authority (NPPA) grants exemption from Drugs Price Control Order (DPCO) 2013 to Torrent Pharmaceuticals for their formulation of Tapentadol Nasal Spray.

Subscribe to NPPA